Expanded-Access Ipilimumab in Czech Republic for Melanoma

Trial Profile

Expanded-Access Ipilimumab in Czech Republic for Melanoma

Active, no longer recruiting
Phase of Trial: Phase III/IV

Latest Information Update: 04 Nov 2015

At a glance

  • Drugs Ipilimumab (Primary)
  • Indications Malignant melanoma
  • Focus Therapeutic Use
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 04 Nov 2015 New trial record
    • 01 Nov 2015 Results published in Anticancer research 35:6303-10, No.11
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top